Journal of gastroenterology · 2018
Clinical guidelines for primary sclerosing cholangitis 2017.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Isayama Hiroyuki, Tazuma Susumu, Kokudo Norihiro, Tanaka Atsushi, Tsuyuguchi Toshio, Nakazawa Takahiro, Notohara Kenji, Mizuno Suguru, Akamatsu Nobuhisa, Serikawa Masahiro, Naitoh Itaru, Hirooka Yoshiki, Wakai Toshifumi, Itoi Takao, Ebata Tomoki, Okaniwa Shinji, Kamisawa Terumi, Kawashima Hiroki, Kanno Atsushi, Kubota Keiichi, Tabata Masami, Unno Michiaki, Takikawa Hajime, PSC guideline committee Members: Ministry of Health, Labour and Welfare (Japan) Research Project, The Intractable Hepatobiliary Disease Study Group
Аннотация
BACKGROUND: Primary sclerosing cholangitis (PSC) is relatively rare disease and pathogenesis and methods of treatments were still not established. Then, we had conducted the making clinical guidelines to manage patients with PSC based on the literature review and expert opinions. These clinical guidelines were made for the medical doctors on the management of PSC, except child case of PSC.
METHODS: We had employed modified Delphi method. The production committee decided guidelines, strength of recommendations and evidence level after reviewed literatures systematically, and The Expert panel evaluated those. The Scientific Committee of the Japan Biliary Association (JBA) evaluated revised guidelines, and the Public comments were collected on web site of JBA.
RESULTS: We had made 16 guidelines about epidemiology/pathophysiology, diagnostics, therapy and prognosis. Also, we had made both diagnostic and therapeutic flow chart.
CONCLUSIONS: We hope that these guidelines will contribute to the improvement and development of the medical care of PSC.
METHODS: We had employed modified Delphi method. The production committee decided guidelines, strength of recommendations and evidence level after reviewed literatures systematically, and The Expert panel evaluated those. The Scientific Committee of the Japan Biliary Association (JBA) evaluated revised guidelines, and the Public comments were collected on web site of JBA.
RESULTS: We had made 16 guidelines about epidemiology/pathophysiology, diagnostics, therapy and prognosis. Also, we had made both diagnostic and therapeutic flow chart.
CONCLUSIONS: We hope that these guidelines will contribute to the improvement and development of the medical care of PSC.